In recognition of the unprecedented and ongoing challenges facing the library and research communities worldwide, there will be no increase in The Company of Biologists' e-journal prices in 2021.
As a not-for-profit publisher committed to maximising the availability of high-quality biological science research, we are keen to support our authors, readers and library customers as far as possible during these difficult times.
We are therefore freezing fees for e-access to our subscription journals - Development, Journal of Cell Science and Journal of Experimental Biology - until 31 December 2021. This applies to both new and existing customers. Article processing charges (APCs) will also remain at 2020 levels throughout 2021.
In addition, we are waiving 2021 price increases for the two-year Read & Publish Open Access agreements we have signed with national library consortia - Jisc in the UK, IReL in Ireland, and MALMAD in Israel - and with individual institutions.
"Our mission is to support and inspire the biological community, and we want to ensure that the highest quality research continues to be available as widely as possible during these uncertain times and beyond. As a result, we have taken the decision to freeze our e-journal prices in 2021," says Matthew Freeman FRS, Chairman of The Company of Biologists and Head of the Dunn School of Pathology at the University of Oxford.
"We are also supporting the library and research community through our Read & Publish initiative which offers libraries a cost-neutral transition to Open Access with free and unlimited Open Access publishing for corresponding authors."
About The Company of Biologists
The Company of Biologists is a not-for-profit publishing company dedicated to supporting and inspiring the biological community. We publish five specialist peer-reviewed journals - three hybrid journals (Development, Journal of Cell Science, and Journal of Experimental Biology), and two Open Access journals (Disease Models & Mechanisms, and Biology Open). We also host scientific meetings and workshops, and provide a variety of grants to the scientific community.
Our Read & Publish Open Access initiative was launched in November 2019, and we have signed national-level consortia agreements with Jisc in the UK, IReL in Ireland, and MALMAD in Israel, as well as with individual institutions.
For further information: